Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Jul;94(28):e1147.
doi: 10.1097/MD.0000000000001147.

Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports

Affiliations
Case Reports

Neurological Manifestations in Parry-Romberg Syndrome: 2 Case Reports

Justine Vix et al. Medicine (Baltimore). 2015 Jul.

Abstract

Parry-Romberg syndrome (PRS) is a variant of morphea usually characterized by a slowly progressive course. Clinical and radiological involvement of the central nervous system may be observed in PRS. We describe 2 patients with PRS and neurological symptoms (one with trigeminal neuralgia associated with deafness, and the second with hemifacial pain associated with migraine without aura) in conjunction with abnormal cerebral MRI including white matter T2 hyperintensities and enhancement with gadolinium. Despite the absence of specific immunosuppressive treatments, both patients have presented stable imaging during follow-up without any clinical neurologic progression. We have performed a large review of the medical literature on patients with PRS and neurological involvement (total of 129 patients). Central nervous system involvement is frequent among PRS patients and is inconsistently associated with clinical abnormalities. These various neurological manifestations include seizures, headaches, movement disorders, neuropsychological symptoms, and focal symptoms. Cerebral MRI may reveal frequent abnormalities, which can be bilateral or more often homolateral to the skin lesions, localized or so widespread so as to involve the whole hemisphere: T2 hyperintensities, mostly in the subcortical white matter, gadolinium enhancement, brain atrophy, and calcifications. These radiological lesions do not usually progress over time. Steroids or immunosuppressive treatments are controversial since it remains unclear to what extent they are beneficial and there is often no neurological progression.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

FIGURE 1
FIGURE 1
Case 1 (A and B): right facial atrophy with frontal linear scleroderma en coup de sabre (A) and an area of alopecia (B). Case 2 (C and D): left facial atrophy with ptosis (C) and en coup de sabre forehead (D).
FIGURE 2
FIGURE 2
Case 1 (A–D): MRI axial T2-FLAIR (A): hyperintensities of the right hemisphere affecting posterior part of the corpus callosum, occipital white matter, anterior limb of the internal capsule, and caudate nucleus. MRI axial susceptibility weighted imaging (B): numerous right microhemorrhages of the caudate nucleus and occipital area. MRI with coronal T1 postcontrast image shows a small gadolinium enhancement of the right several caudate nucleus (C). MR proton spectroscopy: markedly decreased NAA resonance associated with a slightly increased choline resonance without free lipids or lactate resonance (D). Case 2 (E and F): MRI axial T2-FLAIR (E): large hyperintensity of the right hemisphere affecting frontal white matter and multiple bilateral small lesions of the white matter. MRI with axial T1 postcontrast image with heterogeneous gadolinium enhancement of the right frontal white matter (F).

References

    1. Kister I, Inglese M, Laxer RM, et al. Neurologic manifestations of localized scleroderma: a case report and literature review. Neurology 2008; 71:1538–1545. - PubMed
    1. Doolittle DA, Lehman VT, Schwartz KM, et al. CNS imaging findings associated with Parry–Romberg syndrome and en coup de sabre: correlation to dermatologic and neurologic abnormalities. Neuroradiology 2014; 57:21–34. - PubMed
    1. El-Kehdy J, Abbas O, Rubeiz N. A review of Parry–Romberg syndrome. J Am Acad Dermatol 2012; 67:769–784. - PubMed
    1. Stone J. Parry-Romberg syndrome: a global survey of 205 patients using the Internet. Neurology 2003; 61:674–676. - PubMed
    1. Bielsa Marsol I. Update on the classification and treatment of localized scleroderma. Actas Dermosifiliogr 2013; 104:654–666. - PubMed

Publication types